June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Transscleral Optical Phase Imaging of healthy human Retinal Pigment Epithelium
Author Affiliations & Notes
  • Laura Kowalczuk
    Laboratory of Applied Photonic Devices (LAPD), Ecole Polytechnique Federale de Lausanne Faculte des Sciences et Techniques de l'Ingenieur, Lausanne, Switzerland
    Jules-Gonin Eye Hospital, Fondation Asile des aveugles, Universite de Lausanne Faculte de biologie et medecine, Lausanne, VD, Switzerland
  • Remy Dornier
    EarlySight SA, Switzerland
  • Irmela Mantel
    Jules-Gonin Eye Hospital, Fondation Asile des aveugles, Universite de Lausanne Faculte de biologie et medecine, Lausanne, VD, Switzerland
  • Antonio Iskandar
    Jules-Gonin Eye Hospital, Fondation Asile des aveugles, Universite de Lausanne Faculte de biologie et medecine, Lausanne, VD, Switzerland
  • Aurelia Gryczka
    Jules-Gonin Eye Hospital, Fondation Asile des aveugles, Universite de Lausanne Faculte de biologie et medecine, Lausanne, VD, Switzerland
  • Aurelie Navarro
    Jules-Gonin Eye Hospital, Fondation Asile des aveugles, Universite de Lausanne Faculte de biologie et medecine, Lausanne, VD, Switzerland
  • Fanny Jeunet
    Jules-Gonin Eye Hospital, Fondation Asile des aveugles, Universite de Lausanne Faculte de biologie et medecine, Lausanne, VD, Switzerland
  • Francine F Behar-Cohen
    Centre de Recherche des Cordeliers, From physiopathology of ocular diseases to clinical developments, INSERM, Paris, Île-de-France, France
    Ophtalmopôle, Cochin Hospital, Assistance Publique - Hopitaux de Paris, Paris, Île-de-France, France
  • Christophe Moser
    Laboratory of Applied Photonic Devices (LAPD), Ecole Polytechnique Federale de Lausanne Faculte des Sciences et Techniques de l'Ingenieur, Lausanne, Switzerland
  • Mathieu Kunzi
    EarlySight SA, Switzerland
  • Timothe Laforest
    EarlySight SA, Switzerland
  • Footnotes
    Commercial Relationships   Laura Kowalczuk, EIT Health (F); Remy Dornier, EarlySight SA (E); Irmela Mantel, EIT Health (F); Antonio Iskandar, None; Aurelia Gryczka, None; Aurelie Navarro, None; Fanny Jeunet, None; Francine Behar-Cohen, EarlySight SA (I), EarlySight SA (P); Christophe Moser, EarlySight SA (I), EarlySight SA (P); Mathieu Kunzi, EarlySight SA (I), EarlySight SA (E), EarlySight SA (P); Timothe Laforest, EarlySight SA (I), EarlySight SA (E), EarlySight SA (P)
  • Footnotes
    Support  EIT Health Grant: 20694 ASSESS [retinAl phaSe contraSt imaging for Early diagnoSiS]
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1915. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Laura Kowalczuk, Remy Dornier, Irmela Mantel, Antonio Iskandar, Aurelia Gryczka, Aurelie Navarro, Fanny Jeunet, Francine F Behar-Cohen, Christophe Moser, Mathieu Kunzi, Timothe Laforest; Transscleral Optical Phase Imaging of healthy human Retinal Pigment Epithelium. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1915.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The retinal camera using Transscleral Optical Phase Imaging (TOPI) provides in vivo images of retinal pigment epithelium (RPE) cells. We performed a clinical study to characterize healthy RPE cells and to assess the repeatability and the safety of the RPE imaging.

Methods : Healthy volunteers were recruited. After a standard eye examination, spectral domain optical coherence tomography, infrared, autofluorescence and color fundus imaging, they underwent TOPI examination. Six 5.04x5.04°, high resolution, in vivo images of RPE cells at different locations, associated with 30x30° infrared reflectance images, were acquired per eye. The ophthalmic examination was repeated 1 to 3 weeks after TOPI. RPE images were analyzed with a custom automated software to extract cell features. The coefficient of variation (CoV) of three parameters was established on 31 areas, imaged 3 to 7 times and realigned.

Results : Included were 52 eyes (axial length 24.1±0.96 mm) of 31 participants (age 36.5±13.2 years, range 21-70; 20 males, 11 females). Multimodal imaging showed no difference before and after TOPI. The cell features extracted from the RPE images covering an eccentricity of 1.9° to 16.9° from the fovea were: RPE density 3610±321 cells/µm2, cell area 238±23 µm2, intercellular distance 14.3±1.1 µm, circularity 0.88±0.019, elongation 0.63±0.025, border distance CoV 0.16±0.013, solidity 0.95±0.001. The number of neighboring cells was close to 5.7±0.1 whatever the age, eccentricity and axial length. Cell density remained constant with age and eccentricity, while it decreased with axial length (R20.62). Morphological features slightly varied with age, with reduced circularity (R20.22), increased elongation (R20.21) and border distance CoV (R20.22). The CoV calculated for density, area and intercellular distance were 3.9±1.7%, 4.4±1.9% and 2.7±3.1.

Conclusions : The present study demonstrates that in vivo human RPE imaging using TOPI is safe and repeatable. The quantitative analysis provides the first and significant database of in vivo RPE cell features, consistent with the previous in-vivo studies on RPE cells, that can be used as normative database for future diagnostics of retinal diseases at the single cell level.

This is a 2021 ARVO Annual Meeting abstract.

 

Representation of the 6 locations of the RPE images: four centered on the fovea at an eccentricity of 3.8° (1-4), one foveal (5) and one to the discretion of the investigator (6).

Representation of the 6 locations of the RPE images: four centered on the fovea at an eccentricity of 3.8° (1-4), one foveal (5) and one to the discretion of the investigator (6).

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×